2010 to 2021 Saw Rise in Postpartum Depression
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- Diagnosis of postpartum depression increased significantly across all racial and ethnic groups and body mass index categories over the past decade, according to a study published online Nov. 20 in JAMA Network Open.
Nehaa Khadka, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues evaluated recent trends in postpartum depression to see how these trends are associated with race, ethnicity, and prepregnancy body mass index. The analysis included electronic health record data, with live and stillbirths at ≥20 weeks of gestation, for 442,308 pregnancies with delivery between 2010 and 2021.
The researchers found that postpartum depression prevalence doubled during the study period, increasing from 9.4 percent in 2010 to 19.0 percent in 2021. There were differences seen in increase by race and ethnicity, with the largest increases among Asian and Pacific Islander participants (280 percent increase) and non-Hispanic Black women (140 percent increase). Across body mass index categories, PPD rates increased, particularly among individuals with obesity (class I) and morbid obesity (class II/III).
"While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-24 00:00
Read more
- Phanes Therapeutics’ PT217 Granted Fast Track Designation by the FDA for NEPC
- Clinical Practice Guideline Updated for Radiation Therapy for Rectal Cancer
- Fetal Aneuploid Tests Can Spot Occult Cancer in Pregnant Women
- Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis
- Phase 2 Data From the Ongoing Hibiscus Study Shows Promise That Investigational Etavopivat Could Reduce the Incidence of Vaso-occlusive Crises in People With Sickle Cell Disease
- Elton John Says He Has Lost His Sight
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions